ReP USP - Resultado da busca

Artigo de periodico
Evaluation of the neuroprotective potential of benzylidene digoxin 15 against oxidative stress in a neuroinflammation models induced by lipopolysaccharide and on neuronal differentiation of hippocampal neural precursor cells (2025)
Cordeiro, Gilvânia A.; Faria, Jessica A.; Anjos, Leticia Pavan dos ; Garcia, Israel José Pereira ; Neves, Eduarda P. F. I.; Lima, Gustavo Fernando de Frazão; Campos, Hericle Mesquita ; Ferreira, Pâmela Y.; Ghedini, Paulo C. ; Lima, Maira C.; Villar, José Augusto Ferreira Perez ; Orellana, Ana Maria Marques ; Barbosa, Leandro Augusto De Oliveira ; Leite, Jacqueline Alves ; Santos, Hérica de Lima ; Scavone, Cristoforo ; Kawamoto, Elisa Mitiko
Fonte: Frontiers in Pharmacology. Unidade: ICB
Assuntos: FARMACOLOGIA, CEREBELO, ESTRESSE OXIDATIVO, ANTIOXIDANTES, COMPORTAMENTO ANIMAL, RATOS WISTAR, CAMUNDONGOS, SUPERÓXIDO DISMUTASE, HIPOCAMPU DE ANIMAL, LIPOPOLISSACARÍDEOS, CÓRTEX PRÉ-FRONTAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CORDEIRO, Gilvânia A. et al. Evaluation of the neuroprotective potential of benzylidene digoxin 15 against oxidative stress in a neuroinflammation models induced by lipopolysaccharide and on neuronal differentiation of hippocampal neural precursor cells. Frontiers in Pharmacology, v. 16, p. 17 , 2025Tradução . . Disponível em: https://doi.org/10.3389/fphar.2025.1537720. Acesso em: 23 nov. 2025.
APA
Cordeiro, G. A., Faria, J. A., Anjos, L. P. dos, Garcia, I. J. P., Neves, E. P. F. I., Lima, G. F. de F., et al. (2025). Evaluation of the neuroprotective potential of benzylidene digoxin 15 against oxidative stress in a neuroinflammation models induced by lipopolysaccharide and on neuronal differentiation of hippocampal neural precursor cells. Frontiers in Pharmacology, 16, 17 . doi:10.3389/fphar.2025.1537720
NLM
Cordeiro GA, Faria JA, Anjos LP dos, Garcia IJP, Neves EPFI, Lima GF de F, Campos HM, Ferreira PY, Ghedini PC, Lima MC, Villar JAFP, Orellana AMM, Barbosa LADO, Leite JA, Santos H de L, Scavone C, Kawamoto EM. Evaluation of the neuroprotective potential of benzylidene digoxin 15 against oxidative stress in a neuroinflammation models induced by lipopolysaccharide and on neuronal differentiation of hippocampal neural precursor cells [Internet]. Frontiers in Pharmacology. 2025 ; 16 17 .[citado 2025 nov. 23 ] Available from: https://doi.org/10.3389/fphar.2025.1537720
Vancouver
Cordeiro GA, Faria JA, Anjos LP dos, Garcia IJP, Neves EPFI, Lima GF de F, Campos HM, Ferreira PY, Ghedini PC, Lima MC, Villar JAFP, Orellana AMM, Barbosa LADO, Leite JA, Santos H de L, Scavone C, Kawamoto EM. Evaluation of the neuroprotective potential of benzylidene digoxin 15 against oxidative stress in a neuroinflammation models induced by lipopolysaccharide and on neuronal differentiation of hippocampal neural precursor cells [Internet]. Frontiers in Pharmacology. 2025 ; 16 17 .[citado 2025 nov. 23 ] Available from: https://doi.org/10.3389/fphar.2025.1537720
Artigo de periodico
Cardiovascular effects of 6-nitrodopamine, adrenaline, noradrenaline, and dopamine in normotensive and hypertensive rats (2025)
Fuguhara, Vivian de Lima ; Oliveira, Mariana Gonçalves de ; Silva, Carlos Alberto Aguiar da; Guazelli, Pedro Renato; Peterson, Larryn W. ; De Nucci, Gilberto
Fonte: Frontiers in Pharmacology. Unidades: ICB, FMRP
Assuntos: FARMACOLOGIA, FÁRMACOS (SISTEMA CARDIOVASCULAR), CATECOLAMINAS, FREQUÊNCIA CARDÍACA, PRESSÃO SANGUÍNEA, ÓXIDO NÍTRICO, IMUNOENSAIO, ENZIMAS, RATOS WISTAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FUGUHARA, Vivian de Lima et al. Cardiovascular effects of 6-nitrodopamine, adrenaline, noradrenaline, and dopamine in normotensive and hypertensive rats. Frontiers in Pharmacology, v. 16, p. 10 , 2025Tradução . . Disponível em: https://doi.org/10.3389/fphar.2025.1557997. Acesso em: 23 nov. 2025.
APA
Fuguhara, V. de L., Oliveira, M. G. de, Silva, C. A. A. da, Guazelli, P. R., Peterson, L. W., & De Nucci, G. (2025). Cardiovascular effects of 6-nitrodopamine, adrenaline, noradrenaline, and dopamine in normotensive and hypertensive rats. Frontiers in Pharmacology, 16, 10 . doi:10.3389/fphar.2025.1557997
NLM
Fuguhara V de L, Oliveira MG de, Silva CAA da, Guazelli PR, Peterson LW, De Nucci G. Cardiovascular effects of 6-nitrodopamine, adrenaline, noradrenaline, and dopamine in normotensive and hypertensive rats [Internet]. Frontiers in Pharmacology. 2025 ; 16 10 .[citado 2025 nov. 23 ] Available from: https://doi.org/10.3389/fphar.2025.1557997
Vancouver
Fuguhara V de L, Oliveira MG de, Silva CAA da, Guazelli PR, Peterson LW, De Nucci G. Cardiovascular effects of 6-nitrodopamine, adrenaline, noradrenaline, and dopamine in normotensive and hypertensive rats [Internet]. Frontiers in Pharmacology. 2025 ; 16 10 .[citado 2025 nov. 23 ] Available from: https://doi.org/10.3389/fphar.2025.1557997
Artigo de periodico
The identification of adenylyl cyclase modulators as potential receptors for 6-nitrodopamine in human-induced pluripotent stem cell (hiPSC)-derived cardiomyocytes and their relevance in heart inotropism (2025)
Cipollone, Irene; Monaco, Vittoria ; Britto Júnior, José ; Lima, Antonio Tiago ; Antunes, Edson ; Pupo, André Sampaio ; Iacobucci, Ilaria; Cozzolino, Flora ; Monti, Maria; Parisi, Silvia; Divisato, Giuseppina ; Cascone, Emanuela ; Simone, Alfonso de ; Corvino, Angela ; Fiorino, Ferdinando ; Frecentese, Francesco ; Santagada, Vincenzo ; Severino, Beatrice ; Sparaco, Rosa ; Cinque, Pierfrancesco; Vertuccio, Stefania ; Caliendo, Giuseppe ; De Nucci, Gilberto
Fonte: Frontiers in Pharmacology. Unidade: ICB
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CIPOLLONE, Irene et al. The identification of adenylyl cyclase modulators as potential receptors for 6-nitrodopamine in human-induced pluripotent stem cell (hiPSC)-derived cardiomyocytes and their relevance in heart inotropism. Frontiers in Pharmacology, v. 16, 2025Tradução . . Disponível em: https://doi.org/10.3389/fphar.2025.1597035. Acesso em: 23 nov. 2025.
APA
Cipollone, I., Monaco, V., Britto Júnior, J., Lima, A. T., Antunes, E., Pupo, A. S., et al. (2025). The identification of adenylyl cyclase modulators as potential receptors for 6-nitrodopamine in human-induced pluripotent stem cell (hiPSC)-derived cardiomyocytes and their relevance in heart inotropism. Frontiers in Pharmacology, 16. doi:10.3389/fphar.2025.1597035
NLM
Cipollone I, Monaco V, Britto Júnior J, Lima AT, Antunes E, Pupo AS, Iacobucci I, Cozzolino F, Monti M, Parisi S, Divisato G, Cascone E, Simone A de, Corvino A, Fiorino F, Frecentese F, Santagada V, Severino B, Sparaco R, Cinque P, Vertuccio S, Caliendo G, De Nucci G. The identification of adenylyl cyclase modulators as potential receptors for 6-nitrodopamine in human-induced pluripotent stem cell (hiPSC)-derived cardiomyocytes and their relevance in heart inotropism [Internet]. Frontiers in Pharmacology. 2025 ; 16[citado 2025 nov. 23 ] Available from: https://doi.org/10.3389/fphar.2025.1597035
Vancouver
Cipollone I, Monaco V, Britto Júnior J, Lima AT, Antunes E, Pupo AS, Iacobucci I, Cozzolino F, Monti M, Parisi S, Divisato G, Cascone E, Simone A de, Corvino A, Fiorino F, Frecentese F, Santagada V, Severino B, Sparaco R, Cinque P, Vertuccio S, Caliendo G, De Nucci G. The identification of adenylyl cyclase modulators as potential receptors for 6-nitrodopamine in human-induced pluripotent stem cell (hiPSC)-derived cardiomyocytes and their relevance in heart inotropism [Internet]. Frontiers in Pharmacology. 2025 ; 16[citado 2025 nov. 23 ] Available from: https://doi.org/10.3389/fphar.2025.1597035
Artigo de periodico
Polymorphisms in CYP3A5, CYP3A4, and ABCB1 genes: implications for calcineurin inhibitors therapy in hematopoietic cell transplantation recipients—a systematic review (2025)
Costa Junior, Luiz Carlos da ; Alves, Daniely Regina Freitas ; Leão, Amanda Melo Leite ; Monteiro, Hayra de Andrade Vieira; Tavares, Rita de Cássia Barbosa da Silva; Moreira, Maria Claudia Rodrigues; Visacri, Marília Berlofa ; Fernandez, Teresa de Souza ; Santos, Paulo Caleb Junior de Lima
Fonte: Frontiers in Pharmacology. Unidades: FCF, FM
Assuntos: POLIMORFISMO, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA JUNIOR, Luiz Carlos da et al. Polymorphisms in CYP3A5, CYP3A4, and ABCB1 genes: implications for calcineurin inhibitors therapy in hematopoietic cell transplantation recipients—a systematic review. Frontiers in Pharmacology, v. 16, p. 1-18, 2025Tradução . . Disponível em: https://dx.doi.org/10.3389/fphar.2025.1569353. Acesso em: 23 nov. 2025.
APA
Costa Junior, L. C. da, Alves, D. R. F., Leão, A. M. L., Monteiro, H. de A. V., Tavares, R. de C. B. da S., Moreira, M. C. R., et al. (2025). Polymorphisms in CYP3A5, CYP3A4, and ABCB1 genes: implications for calcineurin inhibitors therapy in hematopoietic cell transplantation recipients—a systematic review. Frontiers in Pharmacology, 16, 1-18. doi:10.3389/fphar.2025.1569353
NLM
Costa Junior LC da, Alves DRF, Leão AML, Monteiro H de AV, Tavares R de CB da S, Moreira MCR, Visacri MB, Fernandez T de S, Santos PCJ de L. Polymorphisms in CYP3A5, CYP3A4, and ABCB1 genes: implications for calcineurin inhibitors therapy in hematopoietic cell transplantation recipients—a systematic review [Internet]. Frontiers in Pharmacology. 2025 ; 16 1-18.[citado 2025 nov. 23 ] Available from: https://dx.doi.org/10.3389/fphar.2025.1569353
Vancouver
Costa Junior LC da, Alves DRF, Leão AML, Monteiro H de AV, Tavares R de CB da S, Moreira MCR, Visacri MB, Fernandez T de S, Santos PCJ de L. Polymorphisms in CYP3A5, CYP3A4, and ABCB1 genes: implications for calcineurin inhibitors therapy in hematopoietic cell transplantation recipients—a systematic review [Internet]. Frontiers in Pharmacology. 2025 ; 16 1-18.[citado 2025 nov. 23 ] Available from: https://dx.doi.org/10.3389/fphar.2025.1569353
Artigo de periodico
β-blockers and statins: exploring the potential off-label applications in breast, colorectal, prostate, and lung cancers (2024)
Braga, Pedro Gabriel Senger ; Vieira, Janaina da Silva ; Gurgel, Aline Rachel Bezerra ; Brum, Patrícia Chakur
Fonte: Frontiers in Pharmacology. Unidades: EEFE, FM, ICB
Assuntos: REPOSICIONAMENTO DE FÁRMACOS, NEOPLASIAS, BETA-BLOQUEADORES, ESTATINAS, SOBREVIVÊNCIA LIVRE DE DOENÇA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRAGA, Pedro Gabriel Senger et al. β-blockers and statins: exploring the potential off-label applications in breast, colorectal, prostate, and lung cancers. Frontiers in Pharmacology, v. 15, 2024Tradução . . Disponível em: https://doi.org/10.3389/fphar.2024.1423502. Acesso em: 23 nov. 2025.
APA
Braga, P. G. S., Vieira, J. da S., Gurgel, A. R. B., & Brum, P. C. (2024). β-blockers and statins: exploring the potential off-label applications in breast, colorectal, prostate, and lung cancers. Frontiers in Pharmacology, 15. doi:10.3389/fphar.2024.1423502
NLM
Braga PGS, Vieira J da S, Gurgel ARB, Brum PC. β-blockers and statins: exploring the potential off-label applications in breast, colorectal, prostate, and lung cancers [Internet]. Frontiers in Pharmacology. 2024 ; 15[citado 2025 nov. 23 ] Available from: https://doi.org/10.3389/fphar.2024.1423502
Vancouver
Braga PGS, Vieira J da S, Gurgel ARB, Brum PC. β-blockers and statins: exploring the potential off-label applications in breast, colorectal, prostate, and lung cancers [Internet]. Frontiers in Pharmacology. 2024 ; 15[citado 2025 nov. 23 ] Available from: https://doi.org/10.3389/fphar.2024.1423502
Artigo de periodico
Endothelium-derived 6-nitrodopamine is the major mechanism by which nitric oxide relaxes the rabbit isolated aorta (2024)
Santos, Eric Xavier dos ; Britto Junior, José ; Ribeiro, João Victor; Quirino Junior, Gilberto ; Lima, Antonio Tiago ; Moraes, Manoel Odorico ; Antunes, Edson ; Schenka, André Almeida ; De Nucci, Gilberto
Fonte: Frontiers in Pharmacology. Unidade: ICB
Assuntos: FARMACOLOGIA, COELHOS, AORTA DE ANIMAL, RECEPTORES DE DOPAMINA, CATECOLAMINAS, ÓXIDO NÍTRICO, ENDOTÉLIO VASCULAR, CROMATOGRAFIA LÍQUIDA, ADRENALINA, ESPECTROMETRIA DE MASSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Eric Xavier dos et al. Endothelium-derived 6-nitrodopamine is the major mechanism by which nitric oxide relaxes the rabbit isolated aorta. Frontiers in Pharmacology, v. 15, p. , 2024Tradução . . Disponível em: https://doi.org/10.3389/fphar.2024.1507802. Acesso em: 23 nov. 2025.
APA
Santos, E. X. dos, Britto Junior, J., Ribeiro, J. V., Quirino Junior, G., Lima, A. T., Moraes, M. O., et al. (2024). Endothelium-derived 6-nitrodopamine is the major mechanism by which nitric oxide relaxes the rabbit isolated aorta. Frontiers in Pharmacology, 15, . doi:10.3389/fphar.2024.1507802
NLM
Santos EX dos, Britto Junior J, Ribeiro JV, Quirino Junior G, Lima AT, Moraes MO, Antunes E, Schenka AA, De Nucci G. Endothelium-derived 6-nitrodopamine is the major mechanism by which nitric oxide relaxes the rabbit isolated aorta [Internet]. Frontiers in Pharmacology. 2024 ; 15 .[citado 2025 nov. 23 ] Available from: https://doi.org/10.3389/fphar.2024.1507802
Vancouver
Santos EX dos, Britto Junior J, Ribeiro JV, Quirino Junior G, Lima AT, Moraes MO, Antunes E, Schenka AA, De Nucci G. Endothelium-derived 6-nitrodopamine is the major mechanism by which nitric oxide relaxes the rabbit isolated aorta [Internet]. Frontiers in Pharmacology. 2024 ; 15 .[citado 2025 nov. 23 ] Available from: https://doi.org/10.3389/fphar.2024.1507802
Artigo de periodico
Impairment of adenosine signaling disrupts early embryo development: unveiling the underlying mechanisms (2024)
Glaser, Talita ; Martins, Patrícia; Beco, Renata; Bento, Carolina Adriane ; Cappellari, Angelica R; Oliveira, Sophia La Banca de; Merkel, Christian A; Sampaio, Vanessa Fernandes Arnaud ; Lameu, Claudiana ; Battastini, Ana Maria ; Ulrich, Henning
Fonte: Frontiers in Pharmacology. Unidades: FM, IQ
Assuntos: ADENOSINA, CÉLULAS-TRONCO, CAFEÍNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GLASER, Talita et al. Impairment of adenosine signaling disrupts early embryo development: unveiling the underlying mechanisms. Frontiers in Pharmacology, v. 14, p. 1-16 art. 1328398, 2024Tradução . . Disponível em: https://dx.doi.org/10.3389/fphar.2023.1328398. Acesso em: 23 nov. 2025.
APA
Glaser, T., Martins, P., Beco, R., Bento, C. A., Cappellari, A. R., Oliveira, S. L. B. de, et al. (2024). Impairment of adenosine signaling disrupts early embryo development: unveiling the underlying mechanisms. Frontiers in Pharmacology, 14, 1-16 art. 1328398. doi:10.3389/fphar.2023.1328398
NLM
Glaser T, Martins P, Beco R, Bento CA, Cappellari AR, Oliveira SLB de, Merkel CA, Sampaio VFA, Lameu C, Battastini AM, Ulrich H. Impairment of adenosine signaling disrupts early embryo development: unveiling the underlying mechanisms [Internet]. Frontiers in Pharmacology. 2024 ; 14 1-16 art. 1328398.[citado 2025 nov. 23 ] Available from: https://dx.doi.org/10.3389/fphar.2023.1328398
Vancouver
Glaser T, Martins P, Beco R, Bento CA, Cappellari AR, Oliveira SLB de, Merkel CA, Sampaio VFA, Lameu C, Battastini AM, Ulrich H. Impairment of adenosine signaling disrupts early embryo development: unveiling the underlying mechanisms [Internet]. Frontiers in Pharmacology. 2024 ; 14 1-16 art. 1328398.[citado 2025 nov. 23 ] Available from: https://dx.doi.org/10.3389/fphar.2023.1328398
Artigo de periodico
Lisinopril increases lung ACE2 levels and SARS-CoV-2 viral load and decreases inflammation but not disease severity in experimental COVID-19 (2024)
Santos, Yasmin Silva ; Gamon, Thaís Helena Martins ; Azevedo, Marcela Santiago Pacheco de ; Bielavsky, Mônica ; Darido, Maria Laura Goussain ; Oliveira, Danielle Bruna Leal de ; Souza, Edmarcia Elisa de ; Luvizotto, Maria Cecília Rui ; Ackerman, Hans Christian; Carvalho, Leonardo José de Moura ; Epiphanio, Sabrina ; Wrenger, Carsten ; Durigon, Edison Luiz ; Marinho, Claudio Romero Farias
Fonte: Frontiers in Pharmacology. Unidades: FCF, ICB, Interunidades em Biotecnologia
Assuntos: PARASITOLOGIA, MICROBIOLOGIA, COVID-19, INIBIDORES DE ENZIMAS, DOENÇAS RESPIRATÓRIAS, ANGIOTENSINA II, SISTEMA RENINA-ANGIOTENSINA, ANTIVIRAIS, CAMUNDONGOS, MODELOS ANIMAIS DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Yasmin Silva et al. Lisinopril increases lung ACE2 levels and SARS-CoV-2 viral load and decreases inflammation but not disease severity in experimental COVID-19. Frontiers in Pharmacology, v. 15, 2024Tradução . . Disponível em: https://doi.org/10.3389/fphar.2024.1414406. Acesso em: 23 nov. 2025.
APA
Santos, Y. S., Gamon, T. H. M., Azevedo, M. S. P. de, Bielavsky, M., Darido, M. L. G., Oliveira, D. B. L. de, et al. (2024). Lisinopril increases lung ACE2 levels and SARS-CoV-2 viral load and decreases inflammation but not disease severity in experimental COVID-19. Frontiers in Pharmacology, 15. doi:10.3389/fphar.2024.1414406
NLM
Santos YS, Gamon THM, Azevedo MSP de, Bielavsky M, Darido MLG, Oliveira DBL de, Souza EE de, Luvizotto MCR, Ackerman HC, Carvalho LJ de M, Epiphanio S, Wrenger C, Durigon EL, Marinho CRF. Lisinopril increases lung ACE2 levels and SARS-CoV-2 viral load and decreases inflammation but not disease severity in experimental COVID-19 [Internet]. Frontiers in Pharmacology. 2024 ; 15[citado 2025 nov. 23 ] Available from: https://doi.org/10.3389/fphar.2024.1414406
Vancouver
Santos YS, Gamon THM, Azevedo MSP de, Bielavsky M, Darido MLG, Oliveira DBL de, Souza EE de, Luvizotto MCR, Ackerman HC, Carvalho LJ de M, Epiphanio S, Wrenger C, Durigon EL, Marinho CRF. Lisinopril increases lung ACE2 levels and SARS-CoV-2 viral load and decreases inflammation but not disease severity in experimental COVID-19 [Internet]. Frontiers in Pharmacology. 2024 ; 15[citado 2025 nov. 23 ] Available from: https://doi.org/10.3389/fphar.2024.1414406
Artigo de periodico
GKT137831 and hydrogen peroxide increase the release of 6-nitrodopamine from the human umbilical artery, rat-isolated right atrium, and rat-isolated vas deferens (2024)
Britto Júnior, José ; Furlaneto, Rafael; Lima, Antonio Tiago ; Oliveira, Mariana Gonçalves de ; Severino, Beatrice ; Caliendo, Giuseppe ; Muscará, Marcelo Nicolas ; De Nucci, Gilberto
Fonte: Frontiers in Pharmacology. Unidade: ICB
Assuntos: FARMACOLOGIA, ÁTRIOS DO CORAÇÃO, PERÓXIDO DE HIDROGÊNIO, ARTÉRIAS UMBILICAIS, ÓXIDO NÍTRICO, RECEPTORES DE DOPAMINA, CATECOLAMINAS, RECEPTORES DE CATECOLAMINA, RATOS, MODELOS ANIMAIS DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRITTO JÚNIOR, José et al. GKT137831 and hydrogen peroxide increase the release of 6-nitrodopamine from the human umbilical artery, rat-isolated right atrium, and rat-isolated vas deferens. Frontiers in Pharmacology, v. 15, p. 13 , 2024Tradução . . Disponível em: https://doi.org/10.3389/fphar.2024.1348876. Acesso em: 23 nov. 2025.
APA
Britto Júnior, J., Furlaneto, R., Lima, A. T., Oliveira, M. G. de, Severino, B., Caliendo, G., et al. (2024). GKT137831 and hydrogen peroxide increase the release of 6-nitrodopamine from the human umbilical artery, rat-isolated right atrium, and rat-isolated vas deferens. Frontiers in Pharmacology, 15, 13 . doi:10.3389/fphar.2024.1348876
NLM
Britto Júnior J, Furlaneto R, Lima AT, Oliveira MG de, Severino B, Caliendo G, Muscará MN, De Nucci G. GKT137831 and hydrogen peroxide increase the release of 6-nitrodopamine from the human umbilical artery, rat-isolated right atrium, and rat-isolated vas deferens [Internet]. Frontiers in Pharmacology. 2024 ; 15 13 .[citado 2025 nov. 23 ] Available from: https://doi.org/10.3389/fphar.2024.1348876
Vancouver
Britto Júnior J, Furlaneto R, Lima AT, Oliveira MG de, Severino B, Caliendo G, Muscará MN, De Nucci G. GKT137831 and hydrogen peroxide increase the release of 6-nitrodopamine from the human umbilical artery, rat-isolated right atrium, and rat-isolated vas deferens [Internet]. Frontiers in Pharmacology. 2024 ; 15 13 .[citado 2025 nov. 23 ] Available from: https://doi.org/10.3389/fphar.2024.1348876
Artigo de periodico
The effect of pregnancy-related hormones on hepatic transporters: studies with premenopausal human hepatocytes (2024)
Benzi, Jhohann Richard de Lima ; Tsang, Yik Pui; Unadkat, Jashvant D
Fonte: Frontiers in Pharmacology. Unidade: FCF
Assuntos: HORMÔNIOS, GRAVIDEZ, EXPRESSÃO GÊNICA, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BENZI, Jhohann Richard de Lima e TSANG, Yik Pui e UNADKAT, Jashvant D. The effect of pregnancy-related hormones on hepatic transporters: studies with premenopausal human hepatocytes. Frontiers in Pharmacology, v. 15, p. 1-13 art. 1440010, 2024Tradução . . Disponível em: https://dx.doi.org/10.3389/fphar.2024.1440010. Acesso em: 23 nov. 2025.
APA
Benzi, J. R. de L., Tsang, Y. P., & Unadkat, J. D. (2024). The effect of pregnancy-related hormones on hepatic transporters: studies with premenopausal human hepatocytes. Frontiers in Pharmacology, 15, 1-13 art. 1440010. doi:10.3389/fphar.2024.1440010
NLM
Benzi JR de L, Tsang YP, Unadkat JD. The effect of pregnancy-related hormones on hepatic transporters: studies with premenopausal human hepatocytes [Internet]. Frontiers in Pharmacology. 2024 ; 15 1-13 art. 1440010.[citado 2025 nov. 23 ] Available from: https://dx.doi.org/10.3389/fphar.2024.1440010
Vancouver
Benzi JR de L, Tsang YP, Unadkat JD. The effect of pregnancy-related hormones on hepatic transporters: studies with premenopausal human hepatocytes [Internet]. Frontiers in Pharmacology. 2024 ; 15 1-13 art. 1440010.[citado 2025 nov. 23 ] Available from: https://dx.doi.org/10.3389/fphar.2024.1440010
Artigo de periodico
Brief research report: repurposing pentoxifylline to treat intense acute swimming–induced delayed-onset muscle soreness in mice: targeting peripheral and spinal cord nociceptive mechanisms (2023)
Borghi, Sergio M.; Zaninelli, Tiago H.; Santos, Telma Saraiva; Bertozzi, Mariana M.; Cardoso, Renato D. R.; Carvalho, Thacyana T.; Ferraz, Camila R.; Camilios-Neto, Doumit; Cunha, Fernando de Queiroz ; Cunha, Thiago Mattar ; Pinho-Ribeiro, Felipe A.; Casagrande, Rubia; Verri Júnior, Waldiceu Aparecido
Fonte: Frontiers in Pharmacology. Unidade: FMRP
Assuntos: CITOCINAS, ESTRESSE OXIDATIVO, NEURÓGLIA, DOR, MEDULA ESPINHAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGHI, Sergio M. et al. Brief research report: repurposing pentoxifylline to treat intense acute swimming–induced delayed-onset muscle soreness in mice: targeting peripheral and spinal cord nociceptive mechanisms. Frontiers in Pharmacology, v. 13, p. 1-9, 2023Tradução . . Disponível em: https://doi.org/10.3389/fphar.2022.950314. Acesso em: 23 nov. 2025.
APA
Borghi, S. M., Zaninelli, T. H., Santos, T. S., Bertozzi, M. M., Cardoso, R. D. R., Carvalho, T. T., et al. (2023). Brief research report: repurposing pentoxifylline to treat intense acute swimming–induced delayed-onset muscle soreness in mice: targeting peripheral and spinal cord nociceptive mechanisms. Frontiers in Pharmacology, 13, 1-9. doi:10.3389/fphar.2022.950314
NLM
Borghi SM, Zaninelli TH, Santos TS, Bertozzi MM, Cardoso RDR, Carvalho TT, Ferraz CR, Camilios-Neto D, Cunha F de Q, Cunha TM, Pinho-Ribeiro FA, Casagrande R, Verri Júnior WA. Brief research report: repurposing pentoxifylline to treat intense acute swimming–induced delayed-onset muscle soreness in mice: targeting peripheral and spinal cord nociceptive mechanisms [Internet]. Frontiers in Pharmacology. 2023 ; 13 1-9.[citado 2025 nov. 23 ] Available from: https://doi.org/10.3389/fphar.2022.950314
Vancouver
Borghi SM, Zaninelli TH, Santos TS, Bertozzi MM, Cardoso RDR, Carvalho TT, Ferraz CR, Camilios-Neto D, Cunha F de Q, Cunha TM, Pinho-Ribeiro FA, Casagrande R, Verri Júnior WA. Brief research report: repurposing pentoxifylline to treat intense acute swimming–induced delayed-onset muscle soreness in mice: targeting peripheral and spinal cord nociceptive mechanisms [Internet]. Frontiers in Pharmacology. 2023 ; 13 1-9.[citado 2025 nov. 23 ] Available from: https://doi.org/10.3389/fphar.2022.950314
Artigo de periodico
Current state of molecular and metabolic strategies for the improvement of L-asparaginase expression in heterologous systems (2023)
Lefin, Nicolás ; Miranda, Javiera; Beltrán, Jorge F ; Belén, Lisandra Herrera ; Effer, Brian ; Pessoa Junior, Adalberto ; Farías, Jorge Gonzalo ; Zamorano, Mauricio
Fonte: Frontiers in Pharmacology. Unidade: FCF
Assuntos: BIOPROCESSOS, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEFIN, Nicolás et al. Current state of molecular and metabolic strategies for the improvement of L-asparaginase expression in heterologous systems. Frontiers in Pharmacology, v. 14, p. 1-21, 2023Tradução . . Disponível em: https://doi.org/10.3389/fphar.2023.1208277. Acesso em: 23 nov. 2025.
APA
Lefin, N., Miranda, J., Beltrán, J. F., Belén, L. H., Effer, B., Pessoa Junior, A., et al. (2023). Current state of molecular and metabolic strategies for the improvement of L-asparaginase expression in heterologous systems. Frontiers in Pharmacology, 14, 1-21. doi:10.3389/fphar.2023.1208277
NLM
Lefin N, Miranda J, Beltrán JF, Belén LH, Effer B, Pessoa Junior A, Farías JG, Zamorano M. Current state of molecular and metabolic strategies for the improvement of L-asparaginase expression in heterologous systems [Internet]. Frontiers in Pharmacology. 2023 ; 14 1-21.[citado 2025 nov. 23 ] Available from: https://doi.org/10.3389/fphar.2023.1208277
Vancouver
Lefin N, Miranda J, Beltrán JF, Belén LH, Effer B, Pessoa Junior A, Farías JG, Zamorano M. Current state of molecular and metabolic strategies for the improvement of L-asparaginase expression in heterologous systems [Internet]. Frontiers in Pharmacology. 2023 ; 14 1-21.[citado 2025 nov. 23 ] Available from: https://doi.org/10.3389/fphar.2023.1208277
Artigo de periodico-carta/editorial
Restoring endoplasmic reticulum proteostasis to treat neurological disorders [Editorial] (2023)
Medinas, Danilo Bilches ; Arshad, Najla; Parakh, Sonam ; Miyamoto, Sayuri ; Zambelli, Vanessa Olzon
Fonte: Frontiers in Pharmacology. Unidade: IQ
Assuntos: SISTEMA NERVOSO, RETÍCULO ENDOPLASMÁTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEDINAS, Danilo Bilches et al. Restoring endoplasmic reticulum proteostasis to treat neurological disorders [Editorial]. Frontiers in Pharmacology. Lausanne: Instituto de Química, Universidade de São Paulo. Disponível em: https://doi.org/10.3389/fphar.2023.1176805. Acesso em: 23 nov. 2025. , 2023
APA
Medinas, D. B., Arshad, N., Parakh, S., Miyamoto, S., & Zambelli, V. O. (2023). Restoring endoplasmic reticulum proteostasis to treat neurological disorders [Editorial]. Frontiers in Pharmacology. Lausanne: Instituto de Química, Universidade de São Paulo. doi:10.3389/fphar.2023.1176805
NLM
Medinas DB, Arshad N, Parakh S, Miyamoto S, Zambelli VO. Restoring endoplasmic reticulum proteostasis to treat neurological disorders [Editorial] [Internet]. Frontiers in Pharmacology. 2023 ; 14 1-3 art. 1176805.[citado 2025 nov. 23 ] Available from: https://doi.org/10.3389/fphar.2023.1176805
Vancouver
Medinas DB, Arshad N, Parakh S, Miyamoto S, Zambelli VO. Restoring endoplasmic reticulum proteostasis to treat neurological disorders [Editorial] [Internet]. Frontiers in Pharmacology. 2023 ; 14 1-3 art. 1176805.[citado 2025 nov. 23 ] Available from: https://doi.org/10.3389/fphar.2023.1176805
Artigo de periodico
Characterization of pharmacogenomic variants in a Brazilian admixed cohort of elderly individuals based on whole-genome sequencing data (2023)
Bertholim-Nasciben, Luciana; Scliar, Marilia O ; Deborto, Guilherme; Thiruvahindrapuram, Bhooma; Scherer, Stephen W; Duarte, Yeda Aparecida de Oliveira ; Zatz, Mayana ; Suarez-Kurtz, Guilherme; Parra, Esteban J; Naslavsky, Michel
Fonte: Frontiers in Pharmacology. Unidades: EE, IB, FSP, FMRP
Assuntos: SEQUENCIAMENTO GENÉTICO, IDOSOS, GENOMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BERTHOLIM-NASCIBEN, Luciana et al. Characterization of pharmacogenomic variants in a Brazilian admixed cohort of elderly individuals based on whole-genome sequencing data. Frontiers in Pharmacology, v. 11, 2023Tradução . . Disponível em: https://doi.org/10.3389/fphar.2023.1178715. Acesso em: 23 nov. 2025.
APA
Bertholim-Nasciben, L., Scliar, M. O., Deborto, G., Thiruvahindrapuram, B., Scherer, S. W., Duarte, Y. A. de O., et al. (2023). Characterization of pharmacogenomic variants in a Brazilian admixed cohort of elderly individuals based on whole-genome sequencing data. Frontiers in Pharmacology, 11. doi:10.3389/fphar.2023.1178715
NLM
Bertholim-Nasciben L, Scliar MO, Deborto G, Thiruvahindrapuram B, Scherer SW, Duarte YA de O, Zatz M, Suarez-Kurtz G, Parra EJ, Naslavsky M. Characterization of pharmacogenomic variants in a Brazilian admixed cohort of elderly individuals based on whole-genome sequencing data [Internet]. Frontiers in Pharmacology. 2023 ; 11[citado 2025 nov. 23 ] Available from: https://doi.org/10.3389/fphar.2023.1178715
Vancouver
Bertholim-Nasciben L, Scliar MO, Deborto G, Thiruvahindrapuram B, Scherer SW, Duarte YA de O, Zatz M, Suarez-Kurtz G, Parra EJ, Naslavsky M. Characterization of pharmacogenomic variants in a Brazilian admixed cohort of elderly individuals based on whole-genome sequencing data [Internet]. Frontiers in Pharmacology. 2023 ; 11[citado 2025 nov. 23 ] Available from: https://doi.org/10.3389/fphar.2023.1178715
Artigo de periodico
Susceptibility of Angiostrongylus cantonensis larvae to anthelmintic drugs (2022)
Roquini, Daniel B.; Silva, Gabriel L.; Ferreira, Leonardo Luiz Gomes ; Andricopulo, Adriano Defini ; Wilairatana, Polrat; Moraes, Josué de
Fonte: Frontiers in Pharmacology. Unidade: IFSC
Assuntos: HELMINTÍASE, QUÍMICA MÉDICA, MODELAGEM MOLECULAR, PLANEJAMENTO DE FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROQUINI, Daniel B. et al. Susceptibility of Angiostrongylus cantonensis larvae to anthelmintic drugs. Frontiers in Pharmacology, v. 13, p. 901459-1-901459-9, 2022Tradução . . Disponível em: https://doi.org/10.3389/fphar.2022.901459. Acesso em: 23 nov. 2025.
APA
Roquini, D. B., Silva, G. L., Ferreira, L. L. G., Andricopulo, A. D., Wilairatana, P., & Moraes, J. de. (2022). Susceptibility of Angiostrongylus cantonensis larvae to anthelmintic drugs. Frontiers in Pharmacology, 13, 901459-1-901459-9. doi:10.3389/fphar.2022.901459
NLM
Roquini DB, Silva GL, Ferreira LLG, Andricopulo AD, Wilairatana P, Moraes J de. Susceptibility of Angiostrongylus cantonensis larvae to anthelmintic drugs [Internet]. Frontiers in Pharmacology. 2022 ; 13 901459-1-901459-9.[citado 2025 nov. 23 ] Available from: https://doi.org/10.3389/fphar.2022.901459
Vancouver
Roquini DB, Silva GL, Ferreira LLG, Andricopulo AD, Wilairatana P, Moraes J de. Susceptibility of Angiostrongylus cantonensis larvae to anthelmintic drugs [Internet]. Frontiers in Pharmacology. 2022 ; 13 901459-1-901459-9.[citado 2025 nov. 23 ] Available from: https://doi.org/10.3389/fphar.2022.901459
Artigo de periodico
Neuroinflammation and neutrophils: modulation by ouabain (2022)
Leite, Jacqueline Alves ; Silva, Luiz Henrique Agra Cavalcante ; Ribeiro, Martina Raissa ; Lima, Geovanni de Morais ; Scavone, Cristoforo ; Mascarenhas, Sandra Rodrigues
Fonte: Frontiers in Pharmacology. Unidade: ICB
Assuntos: FARMACOLOGIA, NEUROFARMACOLOGIA, INFLAMAÇÃO, CITOCINAS, ESTEROIDES, GLICOSÍDEOS, HOMEOSTASE, DOENÇAS NEURODEGENERATIVAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEITE, Jacqueline Alves et al. Neuroinflammation and neutrophils: modulation by ouabain. Frontiers in Pharmacology, v. 13, p. 1-9, 2022Tradução . . Disponível em: https://doi.org/10.3389/fphar.2022.824907. Acesso em: 23 nov. 2025.
APA
Leite, J. A., Silva, L. H. A. C., Ribeiro, M. R., Lima, G. de M., Scavone, C., & Mascarenhas, S. R. (2022). Neuroinflammation and neutrophils: modulation by ouabain. Frontiers in Pharmacology, 13, 1-9. doi:10.3389/fphar.2022.824907
NLM
Leite JA, Silva LHAC, Ribeiro MR, Lima G de M, Scavone C, Mascarenhas SR. Neuroinflammation and neutrophils: modulation by ouabain [Internet]. Frontiers in Pharmacology. 2022 ; 13 1-9.[citado 2025 nov. 23 ] Available from: https://doi.org/10.3389/fphar.2022.824907
Vancouver
Leite JA, Silva LHAC, Ribeiro MR, Lima G de M, Scavone C, Mascarenhas SR. Neuroinflammation and neutrophils: modulation by ouabain [Internet]. Frontiers in Pharmacology. 2022 ; 13 1-9.[citado 2025 nov. 23 ] Available from: https://doi.org/10.3389/fphar.2022.824907
Artigo de periodico
Multiparameter optimization of Trypanocidal cruzain inhibitors with in vivo activity and favorable pharmacokinetics (2022)
Pauli, Ivani; Rezende Junior, Celso de Oliveira ; Slafer, Brian W.; Dessoy, Marco A.; Souza, Mariana Laureano de ; Ferreira, Leonardo Luiz Gomes ; Adjanohun, Abraham L. M.; Ferreira, Rafaela S.; Magalhães, Luma Godoy; Andricopulo, Renata Krogh; Duarte, Simone Michelan ; Del Pintor, Ricardo Vaz; Silva, Fernando B. R. da; Cruz, Fabio C.; Dias, Luiz C.; Andricopulo, Adriano Defini
Fonte: Frontiers in Pharmacology. Unidade: IFSC
Assuntos: DOENÇA DE CHAGAS, TRYPANOSOMA CRUZI, QUÍMICA MÉDICA, MODELAGEM MOLECULAR, PLANEJAMENTO DE FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PAULI, Ivani et al. Multiparameter optimization of Trypanocidal cruzain inhibitors with in vivo activity and favorable pharmacokinetics. Frontiers in Pharmacology, v. 12, n. Ja 2022, p. 774069-1-774069-21 + supplementary material, 2022Tradução . . Disponível em: https://doi.org/10.3389/fphar.2021.774069. Acesso em: 23 nov. 2025.
APA
Pauli, I., Rezende Junior, C. de O., Slafer, B. W., Dessoy, M. A., Souza, M. L. de, Ferreira, L. L. G., et al. (2022). Multiparameter optimization of Trypanocidal cruzain inhibitors with in vivo activity and favorable pharmacokinetics. Frontiers in Pharmacology, 12( Ja 2022), 774069-1-774069-21 + supplementary material. doi:10.3389/fphar.2021.774069
NLM
Pauli I, Rezende Junior C de O, Slafer BW, Dessoy MA, Souza ML de, Ferreira LLG, Adjanohun ALM, Ferreira RS, Magalhães LG, Andricopulo RK, Duarte SM, Del Pintor RV, Silva FBR da, Cruz FC, Dias LC, Andricopulo AD. Multiparameter optimization of Trypanocidal cruzain inhibitors with in vivo activity and favorable pharmacokinetics [Internet]. Frontiers in Pharmacology. 2022 ; 12( Ja 2022): 774069-1-774069-21 + supplementary material.[citado 2025 nov. 23 ] Available from: https://doi.org/10.3389/fphar.2021.774069
Vancouver
Pauli I, Rezende Junior C de O, Slafer BW, Dessoy MA, Souza ML de, Ferreira LLG, Adjanohun ALM, Ferreira RS, Magalhães LG, Andricopulo RK, Duarte SM, Del Pintor RV, Silva FBR da, Cruz FC, Dias LC, Andricopulo AD. Multiparameter optimization of Trypanocidal cruzain inhibitors with in vivo activity and favorable pharmacokinetics [Internet]. Frontiers in Pharmacology. 2022 ; 12( Ja 2022): 774069-1-774069-21 + supplementary material.[citado 2025 nov. 23 ] Available from: https://doi.org/10.3389/fphar.2021.774069
Artigo de periodico
Assessment by ABPM verified the presence of hypertension in patients with self-reported hypertension, pregnant women, as well as differences between ethnicities in women aged 38-39years in the Ribeirão Preto cohort (2022)
Brandão, Tetzi Oliveira; Veiga, Eduardo Carvalho de Arruda ; Levy, Rozeli Ferreira; Damaso, Enio Luis ; Sandrim, Valeria Cristina ; Cavalli, Ricardo de Carvalho
Fonte: Frontiers in Pharmacology. Unidades: FOB, FMRP
Assuntos: HIPERTENSÃO, GESTANTES, COMPLICAÇÕES CARDIOVASCULARES NA GRAVIDEZ, DOENÇAS CARDIOVASCULARES, RIBEIRÃO PRETO (SP)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRANDÃO, Tetzi Oliveira et al. Assessment by ABPM verified the presence of hypertension in patients with self-reported hypertension, pregnant women, as well as differences between ethnicities in women aged 38-39years in the Ribeirão Preto cohort. Frontiers in Pharmacology, v. 13, 2022Tradução . . Disponível em: https://doi.org/10.3389/fphar.2022.992595. Acesso em: 23 nov. 2025.
APA
Brandão, T. O., Veiga, E. C. de A., Levy, R. F., Damaso, E. L., Sandrim, V. C., & Cavalli, R. de C. (2022). Assessment by ABPM verified the presence of hypertension in patients with self-reported hypertension, pregnant women, as well as differences between ethnicities in women aged 38-39years in the Ribeirão Preto cohort. Frontiers in Pharmacology, 13. doi:10.3389/fphar.2022.992595
NLM
Brandão TO, Veiga EC de A, Levy RF, Damaso EL, Sandrim VC, Cavalli R de C. Assessment by ABPM verified the presence of hypertension in patients with self-reported hypertension, pregnant women, as well as differences between ethnicities in women aged 38-39years in the Ribeirão Preto cohort [Internet]. Frontiers in Pharmacology. 2022 ; 13[citado 2025 nov. 23 ] Available from: https://doi.org/10.3389/fphar.2022.992595
Vancouver
Brandão TO, Veiga EC de A, Levy RF, Damaso EL, Sandrim VC, Cavalli R de C. Assessment by ABPM verified the presence of hypertension in patients with self-reported hypertension, pregnant women, as well as differences between ethnicities in women aged 38-39years in the Ribeirão Preto cohort [Internet]. Frontiers in Pharmacology. 2022 ; 13[citado 2025 nov. 23 ] Available from: https://doi.org/10.3389/fphar.2022.992595
Artigo de periodico
Intense acute swimming induces delayed-onset muscle soreness dependent on spinal cord neuroinflammation (2022)
Borghi, Sergio M.; Bussulo, Sylvia K. D.; Pinho-Ribeiro, Felipe A.; Fattori, Victor; Carvalho, Thacyana T.; Rasquel-Oliveira, Fernanda S.; Zaninelli, Tiago H.; Ferraz, Camila R.; Casella, Antônio M. B.; Cunha, Fernando de Queiroz ; Cunha, Thiago Mattar ; Casagrande, Rubia; Verri Júnior, Waldiceu A.
Fonte: Frontiers in Pharmacology. Unidade: FMRP
Assuntos: EXERCÍCIOS DE RESISTÊNCIA MUSCULAR, MEDULA ESPINHAL, INFLAMAÇÃO, DOR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGHI, Sergio M. et al. Intense acute swimming induces delayed-onset muscle soreness dependent on spinal cord neuroinflammation. Frontiers in Pharmacology, v. 12, p. 1-17, 2022Tradução . . Disponível em: https://doi.org/10.3389/fphar.2021.734091. Acesso em: 23 nov. 2025.
APA
Borghi, S. M., Bussulo, S. K. D., Pinho-Ribeiro, F. A., Fattori, V., Carvalho, T. T., Rasquel-Oliveira, F. S., et al. (2022). Intense acute swimming induces delayed-onset muscle soreness dependent on spinal cord neuroinflammation. Frontiers in Pharmacology, 12, 1-17. doi:10.3389/fphar.2021.734091
NLM
Borghi SM, Bussulo SKD, Pinho-Ribeiro FA, Fattori V, Carvalho TT, Rasquel-Oliveira FS, Zaninelli TH, Ferraz CR, Casella AMB, Cunha F de Q, Cunha TM, Casagrande R, Verri Júnior WA. Intense acute swimming induces delayed-onset muscle soreness dependent on spinal cord neuroinflammation [Internet]. Frontiers in Pharmacology. 2022 ; 12 1-17.[citado 2025 nov. 23 ] Available from: https://doi.org/10.3389/fphar.2021.734091
Vancouver
Borghi SM, Bussulo SKD, Pinho-Ribeiro FA, Fattori V, Carvalho TT, Rasquel-Oliveira FS, Zaninelli TH, Ferraz CR, Casella AMB, Cunha F de Q, Cunha TM, Casagrande R, Verri Júnior WA. Intense acute swimming induces delayed-onset muscle soreness dependent on spinal cord neuroinflammation [Internet]. Frontiers in Pharmacology. 2022 ; 12 1-17.[citado 2025 nov. 23 ] Available from: https://doi.org/10.3389/fphar.2021.734091
Artigo de periodico
Evaluation of the nicotine metabolite ratio in smoking patients treated with varenicline and bupropion (2022)
Tomaz, Paulo Roberto Xavier; Gonçalves, Thuane Sales; Santos, Juliana Rocha; Scholz, Jaqueline; Abe, Tania Ogawa; Gaya, Patrícia Viviane; Figueiredo, Eduardo Costa; Faria, Henrique Dipe de; Martins, Isarita; Pego, Ana Miguel Fonseca; Paranhos, Beatriz Aparecida Passos Bismara ; Yonamine, Maurício ; Pereira, Alexandre Costa; Santos, Paulo Caleb Junior Lima
Fonte: Frontiers in Pharmacology. Unidades: FM, FCF
Assuntos: METABÓLITOS, TABAGISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOMAZ, Paulo Roberto Xavier et al. Evaluation of the nicotine metabolite ratio in smoking patients treated with varenicline and bupropion. Frontiers in Pharmacology, v. 13, p. 1-7, 2022Tradução . . Disponível em: https://doi.org/10.3389/fphar.2022.900112. Acesso em: 23 nov. 2025.
APA
Tomaz, P. R. X., Gonçalves, T. S., Santos, J. R., Scholz, J., Abe, T. O., Gaya, P. V., et al. (2022). Evaluation of the nicotine metabolite ratio in smoking patients treated with varenicline and bupropion. Frontiers in Pharmacology, 13, 1-7. doi:10.3389/fphar.2022.900112
NLM
Tomaz PRX, Gonçalves TS, Santos JR, Scholz J, Abe TO, Gaya PV, Figueiredo EC, Faria HD de, Martins I, Pego AMF, Paranhos BAPB, Yonamine M, Pereira AC, Santos PCJL. Evaluation of the nicotine metabolite ratio in smoking patients treated with varenicline and bupropion [Internet]. Frontiers in Pharmacology. 2022 ; 13 1-7.[citado 2025 nov. 23 ] Available from: https://doi.org/10.3389/fphar.2022.900112
Vancouver
Tomaz PRX, Gonçalves TS, Santos JR, Scholz J, Abe TO, Gaya PV, Figueiredo EC, Faria HD de, Martins I, Pego AMF, Paranhos BAPB, Yonamine M, Pereira AC, Santos PCJL. Evaluation of the nicotine metabolite ratio in smoking patients treated with varenicline and bupropion [Internet]. Frontiers in Pharmacology. 2022 ; 13 1-7.[citado 2025 nov. 23 ] Available from: https://doi.org/10.3389/fphar.2022.900112

Unidades USP

ReP

Filtros

Unidades USP

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Grupo de pesquisa

Agência de fomento

Indexado em

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos